EU project to launch five RFID pilot tests

Following a year of research and development, the EU-funded BRIDGE project is now preparing five pilots to test Electronic Product Code (EPC) and Radio Frequency Identification (RFID) technologies.

The pilots, scheduled to start in September, will test RFID across several sectors of industry including retail, pharmaceutical, manufacturing, distribution and logistics, and services.

The Electronic Product Code (EPC) is a family of coding schemes created to succeed the bar code. It was created as a low-cost method of tracking goods using RFID technology. RFID is a method of identifying unique items using radio waves. Typically, a reader communicates with a tag, which holds digital information in a microchip.

BRIDGE (Building Radio frequency IDentification solutions for the Global Environment) is a three-year €7.5 million project funded under the EU's Sixth Framework Programme (FP6). It is made up of a consortium of 30 partners from the worlds of industry and research.

BRIDGE was created to research, develop and implement tools enabling RFID and EPCglobal applications, as well as to drive the acceptance of EPCglobal standards in Europe.

The first pilot to go live will test the use of EPC second-generation technology to track pallets of pharmaceutical products as they move through the supply chain, from the manufacturers through distributor networks and on to hospitals and pharmacies.

"The purpose of the pilot is to use RFID to know where the goods come from, and where they are at any given moment," said Henri Barthel, the coordinator of the BRIDGE project. "With RFID, the idea is that the technology can help companies manage the supply chain in a much more accurate and efficient manner."

The pilot will aim to trace a number of products, identified at the carton and pallet levels using EPC RFID tags and 2-D bar-code labels. According to the organisers, deploying this 'hybrid environment' of RFID and bar-coding will afford them the chance to discover the pros and cons of each technology. In addition to RFID tags and 2-D bar-code labels, the pilot will incorporate a network-based system allowing the participants in the project to store, access and analyse all data collected during the experiment.

Ultimately, the objective of the pilot will be to increase the safety of patients by improving the traceability of pharmaceutical products and certifying the pedigree or authenticity of these as they move from the manufacturer to the final user.

Another pilot will be in the retail sector where BRIDGE will test the use of second generation EPC RFID to track cartons and pallets of clothing from the point of manufacture to the store. The pilot will track the goods as they move across the supply chain, but could also include novel in-store applications such as using RFID tags to identify individual garments, and installing RFID interrogators in dressing rooms so shoppers could obtain detailed product information about the items they are trying on, such as sizes, prices and availability.

Lastly, three more similar pilots will take place in food manufacturing processes, reusable assets and products in-service. The results of all five pilots will be made available by the project as it seeks to promote the uptake of standardised EPC and RFID technology for use in global supply chains.

"Since its inception, RFID has been hailed as the panacea for a more sophisticated and efficient global supply chain," said Mr Barthel. "The BRIDGE project will transform RFID from being an identification technology into providing an EPCglobal based product information network."

For further information, please visit:
http://www.bridge-project.eu

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...